Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Sok Cin Tye, Sieta T. de Vries, Christoph Wanner, Petra Denig, Hiddo J. L. Heerspink

Journal title: Front Pharmacol

Journal publisher: Frontiers Media S.A.

Published year: 2021

DOI identifier: 10.3389/fphar.2021.786706

ISSN: 1663-9812